Laparoscopic and open resection of rectal cancer-is age an effect modifier for short- and long-term survival?


Journal

International journal of colorectal disease
ISSN: 1432-1262
Titre abrégé: Int J Colorectal Dis
Pays: Germany
ID NLM: 8607899

Informations de publication

Date de publication:
May 2019
Historique:
accepted: 06 02 2019
pubmed: 20 2 2019
medline: 9 8 2019
entrez: 20 2 2019
Statut: ppublish

Résumé

Rectal cancer is a frequently diagnosed tumor worldwide. Various studies have shown the noninferiority or even slight superiority of laparoscopic resection. However, there is no clear recommendation on whether age should influence the choice of surgical approach. This study compared outcomes of laparoscopic and open surgery in rectal cancer patients. Perioperative mortality and 5-year overall, relative, and recurrence-free survival rates were analyzed separately for three age groups. Data originate from 30 regional German cancer registries that cover approximately one quarter of the German population. All primary nonmetastatic rectal adenocarcinoma cases with surgery between 2005 and 2014 were eligible for inclusion. To compare survival rates, Kaplan-Meier analysis, a relative survival model, and multivariable Cox regression were used; a sensitivity analysis assessed bias by exclusion. Ten thousand seven hundred fifty-four patients were included in the analysis. The mean laparoscopy rate was 23.0% and increased over time. Analysis of 30-day postoperative mortality rates revealed advantages for laparoscopically treated patients, although the significance level was not reached in any age group. Regarding 5-year overall survival, laparoscopy generally seems to be the superior approach, whereas for recurrence-free survival, an age-dependent gradient in effect size was observed: with a hazard ratio (HR) of 0.703 for laparoscopy, patients under 60 years benefitted more from the minimally invasive approach than older patients (septuagenarians, HR 0.923). Laparoscopy shows similar results to the open approach in terms of postoperative survival in all age groups. Concerning long-term outcomes, younger patients benefitted most from the minimally invasive approach.

Identifiants

pubmed: 30778670
doi: 10.1007/s00384-019-03265-7
pii: 10.1007/s00384-019-03265-7
doi:

Types de publication

Journal Article

Langues

eng

Pagination

821-828

Références

J Clin Oncol. 2004 May 15;22(10):1785-96
pubmed: 15067027
Comput Methods Programs Biomed. 2006 Mar;81(3):272-8
pubmed: 16510208
Lancet. 2007 Oct 20;370(9596):1453-7
pubmed: 18064739
Crit Rev Oncol Hematol. 2008 Aug;67(2):124-32
pubmed: 18375141
Cochrane Database Syst Rev. 2008 Apr 16;(2):CD003432
pubmed: 18425886
Ann Surg Oncol. 2010 Nov;17(11):2863-9
pubmed: 20552409
Dis Colon Rectum. 2012 Jan;55(1):42-50
pubmed: 22156866
Colorectal Dis. 2012 Dec;14(12):1473-8
pubmed: 22540837
Ann Surg. 2013 May;257(5):916-21
pubmed: 22735713
Int J Cancer. 2013 May 1;132(9):2157-63
pubmed: 23015513
Lancet Oncol. 2013 Mar;14(3):210-8
pubmed: 23395398
PLoS One. 2013 Jul 05;8(7):e68077
pubmed: 23861851
Dis Colon Rectum. 2014 Mar;57(3):303-10
pubmed: 24509451
J Gastrointest Surg. 2015 Jan;19(1):124-31; discussion 131-2
pubmed: 25091847
N Engl J Med. 2015 Apr 2;372(14):1324-32
pubmed: 25830422
Colorectal Dis. 2016 May;18(5):459-67
pubmed: 26408287
J Surg Res. 2016 May 15;202(2):299-307
pubmed: 27229104
Oncotarget. 2017 Nov 6;8(63):106913-106925
pubmed: 29290999
Surg Endosc. 2018 Oct;32(10):4096-4104
pubmed: 29611044
Gesundheitswesen. 2018 Apr 19;:null
pubmed: 29672814
Surg Today. 1993;23(1):21-30
pubmed: 8461602

Auteurs

Teresa Draeger (T)

Tumorzentrum Regensburg - Institut für Qualitätssicherung und Versorgungsforschung der Universität Regensburg, Am BioPark 9, 93053, Regensburg, Germany. teresa.draeger@gmx.de.

Vinzenz Völkel (V)

Tumorzentrum Regensburg - Institut für Qualitätssicherung und Versorgungsforschung der Universität Regensburg, Am BioPark 9, 93053, Regensburg, Germany.

Valentin Schnitzbauer (V)

Universität Regensburg, Universitätsstraße 31, 93053, Regensburg, Germany.

Michael Gerken (M)

Tumorzentrum Regensburg - Institut für Qualitätssicherung und Versorgungsforschung der Universität Regensburg, Am BioPark 9, 93053, Regensburg, Germany.

Stefan Benz (S)

Klinik für Allgemeine-, Viszeral- und Kinderchirurgie, Kliniken Böblingen, Bunsenstr. 120, 71032, Böblingen, Germany.

Monika Klinkhammer-Schalke (M)

Tumorzentrum Regensburg - Institut für Qualitätssicherung und Versorgungsforschung der Universität Regensburg, Am BioPark 9, 93053, Regensburg, Germany.

Alois Fürst (A)

Klinik für Allgemein-, Viszeral-, Thoraxchirurgie und Adipositasmedizin, Caritas Krankenhaus St. Josef Regensburg, Landshuter Str. 65, 93053, Regensburg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH